BioCardia (BCDA) filed a regulatory statement to register up to 549,392 common shares for resale by existing investors from time to time.
The securities consist of 274,696 shares and warrants for an identical number of shares, the company said Wednesday in a filing.
The company won't receive proceeds from the resale of common shares but may receive up to $535,657.20 if all warrants are exercised at $1.95 a share.
BioCardia shares fell 4.7% in recent after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.